Cargando…

Cardiac magnetic resonance in Fabry disease

Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by deficient a-galactosidase A activity that leads to an accumulation of glycolipids, mainly globotriaosylceramide (Gb3) and globotriaosylsphingosine, in affected tissues, including the heart. Cardiovascular involvemen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanzillo, Chiara, Fedele, Elisa, Martino, Annamaria, Ferrazza, Alessandro, Fusco, Armando, Silvetti, Elisa, Canestrelli, Stefano, Romeo, Fabiana, Canali, Emanuele, De Luca, Lucia, Golia, Paolo, Crescenzi, Cinzia, Stefanini, Matteo, Calò, Leonardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	PLACE 2022 Supplement Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132562/ https://www.ncbi.nlm.nih.gov/pubmed/37125302 http://dx.doi.org/10.1093/eurheartjsupp/suad045

Ejemplares similares

Electrocardiogram in arrhytmogenic cardiomyopathy
por: Calò, Leonardo, et al.
Publicado: (2023)

The electrocardiogram in non-ischaemic-dilated cardiomyopathy
por: Crescenzi, Cinzia, et al.
Publicado: (2023)

The value of the 12-lead electrocardiogram in the prediction of sudden cardiac death
por: Calò, Leonardo, et al.
Publicado: (2023)

Echocardiography in cardioembolic stroke prevention
por: Canali, Emanuele, et al.
Publicado: (2023)

Multi-modality imaging for pre-procedural planning of transcatheter mitral valve interventions
por: Tarzia, Pierpaolo, et al.
Publicado: (2023)

MR guided cardiac ablation: how to build an interventional magnetic resonance suite and what's the role of the imaging
por: Fusco, Armando, et al.
Publicado: (2023)

Atrial fibrillation and sympatho–vagal imbalance: from the choice of the antiarrhythmic treatment to patients with syncope and ganglionated plexi ablation
por: Rebecchi, Marco, et al.
Publicado: (2023)

Bempedoic acid: what prospective uses?
por: Jacomelli, Ilaria, et al.
Publicado: (2023)

Optimal management of patients after acute coronary syndrome
por: Panattoni, Germana, et al.
Publicado: (2023)

Cardiac magnetic resonance-guided cardiac ablation: a case series of an early experience
por: De Zan, Giulia, et al.
Publicado: (2023)

The pivotal role of ECG in cardiomyopathies
por: Silvetti, Elisa, et al.
Publicado: (2023)

Ganglionated plexi ablation in the right atrium for the treatment of cardioinhibitory syncope
por: Rebecchi, Marco, et al.
Publicado: (2023)

HeartLogic™: real-world data—efficiency, resource consumption, and workflow optimization
por: Mariani, Marco Valerio, et al.
Publicado: (2023)

Heart failure and telemedicine: where are we and where are we going? Opportunities and critical issues
por: Calò, Leonardo, et al.
Publicado: (2023)

Tissue thickness measured with dielectric-based technology during radiofrequency catheter ablation
por: De Ruvo, Ermenegildo, et al.
Publicado: (2023)

Calcified coronary lesions
por: Cialdella, Pio, et al.
Publicado: (2023)

Acute coronary syndromes and multivessel coronary artery disease
por: Zimbardo, Giuseppe, et al.
Publicado: (2023)

Atrial fibrillation fundamentals: from physiopathology to transcatheter ablation
por: Gaita, Fiorenzo, et al.
Publicado: (2023)

Acute coronary complications in chronic total occlusion interventions
por: Leone, Pier Pasquale, et al.
Publicado: (2023)

The Brugada syndrome: risk stratification
por: Gaita, Fiorenzo, et al.
Publicado: (2023)

Sodium-glucose co-transporter 2 inhibitors in heart failure: an updated evidence-based practical guidance for clinicians
por: Monzo, Luca, et al.
Publicado: (2023)

The implantable cardiac monitor in heart failure patient: a possible new indication?
por: Cicogna, Francesco, et al.
Publicado: (2023)

Pacing of the specialized His–Purkinje conduction system: ‘back to the future’
por: Bressi, Edoardo, et al.
Publicado: (2023)

Stage-specific therapy for hypertrophic cardiomyopathy
por: Argirò, Alessia, et al.
Publicado: (2023)

Evolution of interventional imaging in structural heart disease
por: Agricola, Eustachio, et al.
Publicado: (2023)

Low-dose rivaroxaban: can cardiovascular events be reduced?
por: De Luca, Leonardo
Publicado: (2023)

The PACMAN-AMI trial: a revolution in the treatment of acute coronary syndromes
por: De Luca, Leonardo, et al.
Publicado: (2023)

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
por: Aquaro, Giovanni Donato, et al.
Publicado: (2023)

Acute heart failure: differential diagnosis and treatment
por: Marini, Marco, et al.
Publicado: (2023)

Stabilization of vulnerable plaque in the ACS patient: evidence from HUYGENS studies
por: Zanda, Greca, et al.
Publicado: (2023)

Management of bleeding in patients on direct oral anticoagulants in emergency department: where we are and where we are going
por: De Marco, Francesca, et al.
Publicado: (2023)

Transcatheter ablation in patients with Brugada syndrome
por: Grossi, Stefano, et al.
Publicado: (2023)

Autopsy and sudden death
por: Thiene, Gaetano
Publicado: (2023)

Scarring/arrhythmogenic cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2023)

The role of iron deficiency in heart failure
por: Caminiti, Giuseppe, et al.
Publicado: (2023)

Cardiac computed tomography: from anatomy to function
por: Maragna, Riccardo, et al.
Publicado: (2023)

Cardiac magnetic resonance in ischemic cardiomyopathy: present role and future directions
por: Scatteia, Alessandra, et al.
Publicado: (2023)

Pragmatic electrocardiogram tracings in non-ischaemic dilated cardiomyopathy: diagnostic and prognostic role
por: Pezzato, Andrea, et al.
Publicado: (2023)

HeartInsight: from SELENE HF to implementation in clinical practice
por: Zanotto, Gabriele, et al.
Publicado: (2023)

The Brugada syndrome: pharmacological therapy
por: Giustetto, Carla, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8m5agcj5ilbq1un936rsotgts7